Experience
RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb
December 26, 2023
Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb.
Related contacts
Related Practices & Industries
Carmot Therapeutics Enters Definitive Merger Agreement With Roche
December 3, 2023
Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.
Related contacts
Related Practices & Industries
Moogsoft Agrees to Sell to Dell
July 19, 2023
Cooley advised Moogsoft, an artificial intelligence-driven provider of intelligent monitoring solutions that support DevOps and ITOps, on its agreement to sell to Dell Technologies. Lawyers Steve Tonsfeldt, Mark Tanoury, Sangitha Palaniappa and Allison Peth led the Cooley team advising Moogsoft.
Related contacts
Related Practices & Industries
ThoughtSpot Acquires Mode Analytics
June 27, 2023
Cooley advised ThoughtSpot, an artificial intelligence-powered analytics company, on its definitive agreement to acquire Mode Analytics for $200 million.
Related contacts
Related Practices & Industries
Apollo Endosurgery to Be Acquired by Boston Scientific
February 1, 2023
Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.
Related contacts
Related news and events
RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb
Admissions & credentials
California
Memberships & affiliations
American Bar Association